Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2005
06/30/2005WO2005059550A1 Dna encoding snorf138 and uses thereof
06/30/2005WO2005059549A1 Method for bonding plastic micro chip
06/30/2005WO2005059548A1 Novel mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefor
06/30/2005WO2005059547A2 Assay
06/30/2005WO2005059546A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35)
06/30/2005WO2005059545A2 Diagnostics ans therapeutics for diseases associated with g protein-coupled receptor gpr82 (gpr82)
06/30/2005WO2005059544A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor cckar (cckar)
06/30/2005WO2005059543A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor h963 (h963)
06/30/2005WO2005059542A1 A method and an apparatus for monitoring the water potential of living plant in situ
06/30/2005WO2005059541A1 Apparatus for detecting drugs in a beverage
06/30/2005WO2005059538A1 Protein analysis method
06/30/2005WO2005059536A1 Film-type solid polymer ionomer sensor and sensor cell
06/30/2005WO2005059532A1 Cartridge device for blood analysis
06/30/2005WO2005059529A1 Hydrogen sulfide monitoring system
06/30/2005WO2005059528A1 Optical analysis device
06/30/2005WO2005059517A2 Toll-like receptor assays
06/30/2005WO2005059511A2 Densitometer with pulsing pressure
06/30/2005WO2005059509A2 Biosensors for detecting macromolecules and other analytes
06/30/2005WO2005059508A2 Cellular probes
06/30/2005WO2005059507A2 Biosensor and method of making same
06/30/2005WO2005059504A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
06/30/2005WO2005059181A1 Carbon electrode surface for attachment of dna and protein molecules
06/30/2005WO2005059170A2 Method for the determination of fibrinolytic activity in blood
06/30/2005WO2005059168A1 Methods of identifying, selecting and/or characterizing compounds which modulate the activity of a src family kinase
06/30/2005WO2005059167A1 Method for identifying histone deacetylase inhibitors
06/30/2005WO2005059165A2 Methods for detecting bacterial pathogens
06/30/2005WO2005059163A2 Methods, compositions, and kits for analysis of enzyme activity in cells
06/30/2005WO2005059101A2 Novel sodium channel
06/30/2005WO2005059086A1 Biologically active substance transfer sheet, cell culture kit constituted of cell culture plate and biologically active substance transfer sheet, producing method thereof and method for screening cell culture conditions utilizing the same
06/30/2005WO2005059085A2 Method and device for division of a biological sample by magnetic effect
06/30/2005WO2005059037A1 Reagent for detecting an analyte
06/30/2005WO2005058965A1 Methods and compositions for inhibiting c-met dimerization and activation
06/30/2005WO2005058964A1 Antibody against modified valosine-containing protein
06/30/2005WO2005058963A1 Anti-hiv antibody
06/30/2005WO2005058962A1 Methods of therapy and diagnosis using targeting of cells that express bclp polypeptides
06/30/2005WO2005058957A2 Ztnf 12, a tumor necrosis factor
06/30/2005WO2005058949A1 Protein separation device
06/30/2005WO2005058877A1 Novel chelating agents and highly luminescent and stable chelates and their use
06/30/2005WO2005058865A2 Assay for entactogens
06/30/2005WO2005058864A1 Assay for entactogens
06/30/2005WO2005058478A1 Molecular stamp for printing biomolecules onto a substrate
06/30/2005WO2005058452A2 Purification system
06/30/2005WO2005058373A2 Methods, program products, and systems for single and multi-agent dosing
06/30/2005WO2005058352A2 Treatment of rheumatoid arthritis with galectin-3 antagonists
06/30/2005WO2005058244A2 Novel anti-dc-sign antibodies
06/30/2005WO2005058142A2 Diabetes diagnostic
06/30/2005WO2005058018A2 System and method for plant identification
06/30/2005WO2005044989A3 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same
06/30/2005WO2005044301A3 Use of specific histones for the treatment of parasitic diseases
06/30/2005WO2005043160A3 Ultrasensitive biochemical sensing platform
06/30/2005WO2005042704A3 Differential enzymatic fragmentation
06/30/2005WO2005042016A3 Stabilised compositions
06/30/2005WO2005040825A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20)
06/30/2005WO2005040824A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24)
06/30/2005WO2005040822A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 25 (gpr25)
06/30/2005WO2005040791A3 Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr)
06/30/2005WO2005040758A8 Use of pirfenidone in therapeutic regimens
06/30/2005WO2005040405A3 Detecting microbial contamination in grain and related products
06/30/2005WO2005039381A3 Compositions and processes for analysis of pharmacologic agents in biological samples
06/30/2005WO2005039380A3 Diagnostic agent for malignant melanoma
06/30/2005WO2005038618A3 Lead molecule cross-reaction prediction and optimization system
06/30/2005WO2005034926A3 Non-invasive system for detecting skin cancer
06/30/2005WO2005027886A3 Methods of preventing or treating recurrence of myocardial infarction
06/30/2005WO2005026729A3 Improved method and apparatus for aligning microbeads in order to interrogate the same
06/30/2005WO2005024422A3 Methods for identifying inhibitors
06/30/2005WO2005021576A3 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same
06/30/2005WO2005020125A3 Methods and systems for profiling biological systems
06/30/2005WO2005017093A3 Polypeptides of streptococcus pyogenes
06/30/2005WO2005013890A3 Function and regulation of angiopoietin-3/angiopoietin-4
06/30/2005WO2005012914A3 Method for characterising polypeptides by maldi-tof mas spectrometry
06/30/2005WO2005012912A3 Lamp-1 membrane expression by cancer cells
06/30/2005WO2005012905A8 Coloring sensor
06/30/2005WO2005010482A3 Detection of biomarkers
06/30/2005WO2005008251A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
06/30/2005WO2005006960A3 Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays
06/30/2005WO2005005980A3 Methods for tumor evaluation, identification of anti-tumor agents and treatment
06/30/2005WO2005003767A3 Elemental analysis of tagged biologically active materials
06/30/2005WO2004103293A3 Modulators of the p2y10 receptor useful in altering t lymphocyte function
06/30/2005WO2004102157A3 Improved methods for protein interaction determination
06/30/2005WO2004098741A3 Apparatus and method for detecting live cells with an integrated filter and growth detection device
06/30/2005WO2004097368A3 Improved immunoassays
06/30/2005WO2004092210A3 Molecules having immunomodulatory activity
06/30/2005WO2004091376A3 Medical device for monitoring blood phenylalanine levels
06/30/2005WO2004088273A3 Method of monitoring the operation of gas sensor and system therefor
06/30/2005WO2004074452A3 Multiplex mapping of protein interactions
06/30/2005WO2004065614A3 Suppression of cytotoxic protein conformers
06/30/2005WO2004059321A8 Prp detection method using an aminoglycoside antibiotic
06/30/2005WO2004035611A3 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
06/30/2005WO2004032702A3 Apparatus and method for hematologic analysis
06/30/2005WO2004024898A3 Nematode fatty acid desaturase-like sequences
06/30/2005WO2004018999A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
06/30/2005WO2004016729A3 SYSTEMS AND METHODS FOR CONTROL OF pH AND OTHER REACTOR ENVIRONMENTAL CONDITIONS
06/30/2005WO2004001381A3 Novel raag10 cell surface target and a family of antibodies recognizing that target
06/30/2005WO2003074722A3 Microarrays of cellulose binding chimeric proteins and methods of use thereof
06/30/2005WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/30/2005WO2002009836A3 Methods for solid phase nanoextraction and desorption
06/30/2005US20050144662 Knockout mouse
06/30/2005US20050144661 Robust, broadly applicable bioluminescence signal; demonstrates modification independent and phosphorylation dependent protein interactions; diagnostic and testing tool; transgenic animal models
06/30/2005US20050144654 treating fruitfly Drosophila melanogaster adult males with fly medium containing either of neuroactive compounds strychnine, pentylenetetrazol, pilocarpine hydrochloride, tetraethylammonium chloride, lithium carbonate and ethosuximide, subjecting flies to negative geotaxis and horizontal locomotor assays
06/30/2005US20050143937 Inferential determination of various properties of a gas mixture